IGM Biosciences, Inc. (NASDAQ: IGMS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference [Yahoo! Finance]